DOMH stock icon

Dominari Holdings

1.60 USD
-0.10
5.88%
At close Nov 18, 4:00 PM EST
1 day
-5.88%
5 days
-6.98%
1 month
-11.60%
3 months
0.63%
6 months
-24.88%
Year to date
-37.25%
1 year
-20.00%
5 years
-91.82%
10 years
-99.93%
 

About: Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Employees: 28

0
Funds holding %
of 6,735 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

15% more funds holding

Funds holding: 13 [Q2] → 15 (+2) [Q3]

0.45% less ownership

Funds ownership: 7.76% [Q2] → 7.3% (-0.45%) [Q3]

2% less capital invested

Capital invested by funds: $862K [Q2] → $849K (-$13.1K) [Q3]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Research analyst outlook

We haven’t received any recent analyst ratings for DOMH.

Financial journalist opinion

Charts implemented using Lightweight Charts™